Nomenclature for factors of the HLA system, 1995

Bodmer, JG; Marsh, S. G. E.; Albert,; Bodmer, Walter F.; Bontrop, Ronald E.; Charron, Dominique; Dupont, Bo; Erlich, Henry A.; Mach, Bernard; Mayr, Wolfgang R.

doi:10.1016/0198-8859(95)00071-b

Cited by 91 publications

(36 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…DQ -typing was performed with AmpliType (PE Applied Biosystems, Branchburg, NJ, USA [22]. DQ2 and DQ8 were named corresponding to HLA-DQ serological specificities [23].…”

Section: Hla Genotypesmentioning

confidence: 99%

One Third of HLA DQ2 Homozygous Patients with Type 1 Diabetes Express Celiac Disease-Associated Transglutaminase Autoantibodies

Bao

Babu

et al. 1999

Journal of Autoimmunity

222

146

View full text Add to dashboard Cite

“…DQ -typing was performed with AmpliType (PE Applied Biosystems, Branchburg, NJ, USA [22]. DQ2 and DQ8 were named corresponding to HLA-DQ serological specificities [23].…”

Section: Hla Genotypesmentioning

confidence: 99%

One Third of HLA DQ2 Homozygous Patients with Type 1 Diabetes Express Celiac Disease-Associated Transglutaminase Autoantibodies

Bao

Babu

et al. 1999

Journal of Autoimmunity

222

146

View full text Add to dashboard Cite

“…The second exons of the DQA1 and DQB1 genes were amplified by polymerase chain reaction (PCR) and hybridized to a panel of labeled allele-specific probes in dot-blot experiments (17). The latest nomenclature of the World Health Organization Nomenclature Committee for Factors of the HLA System was used (24).…”

Section: Hla-dq and Insulin Genotypingmentioning

confidence: 99%

Associations of GAD65- and IA-2-Autoantibodies With Genetic Risk Markers in New-Onset IDDM Patients and Their Siblings. The Belgian Diabetes Registry

Vandewalle¹,

Falorni

Lernmark

et al. 1997

Diabetes Care

View full text Add to dashboard Cite

show abstract

“…The latest nomenclature of the World Health Organization committee for factors of the HIA system was used (31).…”

Section: Biological Markersmentioning

confidence: 99%

Epidemiology, Clinical Aspects, and Biology of IDDM Patients Under Age 40 Years: Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry

et al. 1997

View full text Add to dashboard Cite

In Antwerp, the incidence rate of IDDM under age 15 years is intermediately high compared with the rates in other European regions. It is similar in the 15-39 years age-group, but with a marked male predominance. Demographic, clinical, and biological data show the same age-dependent heterogeneity as the data collected nationwide, with 40% ascertainment indicating the representativeness of the latter.

show abstract

Nomenclature for factors of the HLA system, 1995

Cited by 91 publications

References 43 publications

One Third of HLA DQ2 Homozygous Patients with Type 1 Diabetes Express Celiac Disease-Associated Transglutaminase Autoantibodies

One Third of HLA DQ2 Homozygous Patients with Type 1 Diabetes Express Celiac Disease-Associated Transglutaminase Autoantibodies

Associations of GAD65- and IA-2-Autoantibodies With Genetic Risk Markers in New-Onset IDDM Patients and Their Siblings. The Belgian Diabetes Registry

Epidemiology, Clinical Aspects, and Biology of IDDM Patients Under Age 40 Years: Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry

Contact Info

Product

Resources

About